Product: Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC 49884-922-02) and b) 250-count tablets per bottle (NDC 49884-922-04), Rx only, Distributed by: Par Pharmaceutical Companies, Inc., Spring Valley, NY  10977.
Reason for recall: Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.
Recall initiated: 20120629
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated